XiaoMi-AI文件搜索系统
World File Search SystemBioThrax
疫苗说明书第 13.1 节的内容
腺病毒 4 型和 7 型活疫苗口服剂尚未被评估为具有致癌或致突变潜力，或对雄性生育力的损害。 * 炭疽 AVA (BioThrax) 在一项使用怀孕兔子的发育毒性研究中评估了 BioThrax 对胚胎-胎儿和断奶前发育的影响。一组兔子在怀孕前和器官形成期（怀孕第 7 天）被施用 BioThrax 两次。第二组兔子在怀孕前和怀孕第 17 天被施用 BioThrax 两次。BioThrax 以 0.5 毫升/只兔子/次的剂量通过肌肉注射施用。未观察到对交配、生育力、怀孕、分娩、哺乳、胚胎-胎儿或断奶前发育的不良影响。本研究未发现与疫苗相关的胎儿畸形或其他致畸证据。 (CYFENDUS) CYFENDUS 尚未被评估为对动物的致癌性、致突变性或雄性不育性。给雌性大鼠服用 CYFENDUS 对生育力没有影响 * 基孔肯雅病毒
包装插入-Cyfendus
在研究4中，将有效控制的研究，许可的炭疽疫苗Biothrax（吸附的炭疽疫苗）用作比较器。征求了任何剂量的Cyfendus或biothrax之后报道的局部和全身不良反应。cyfendus在第0和2周时以两剂为单位，在第4周给予盐水安慰剂。在第0、2和4周，皮下施用三剂。接受至少一剂Cyfendus的参与者人数为3151，而2898名参与者则获得了Cyfendus的完整两剂治疗方案。There was no notable difference in the frequency of solicited local or systemic adverse reactions after the first or second dose of CYFENDUS, with the exception of itching (10.3% after first CYFENDUS dose vs. 16.8% after second dose), erythema/redness (7.4% after first CYFENDUS dose vs. 14.8% after second dose), swelling (10.2% after first CYFENDUS dose vs.第二剂和发烧后的15.9％（第一次cyfendus剂量后2.7％，第二剂量后5.0％）
佛罗里达镜头 - 有效值
代码说明Flshots Vacc。Type 1 Diphtheria, tetanus toxoids and pertussis DTP 2 Trivalent poliovirus, live, oral OPV 3 Measles, mumps, and rubella virus MMR 4 Measles and rubella virus MR 5 Measles virus MEASLES 6 Rubella virus RUBELLA 7 Mumps virus MUMPS 8 Hepatitis B, pediatric or pediatric/adolescent HEP B PED 9 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed TD PF (TDVAX) 10 Poliovirus, inactivated IPV 11 Pertussis PERTUSSIS 12 Diphtheria antitoxin DIPHTHERIA ANTITOXIN 13 Tetanus immune globulin TIG 14 Immune globulin, unspecified IG UNK 17 Haemophilus influenza type B,未指定的HIB UNK 19杆菌Calmette-Guerin bcg 20 D iPhtheria，Tetanus毒素和细胞的全部百日咳DTAP 21 VARICELLA病毒VZV 22 DTP-HAEMOPHILUS流感型流感型dtp-Haemophilus b型B型B型dtp-Hib dtp-Hib 23 Typhoid, live, oral TYPHOID PO 26 Cholera, unspecified CHOLERA UNK 27 Botulinum antitoxin BOTULINUM 28 Diphtheria and tetanus toxoids, adsorbed, pediatric DT 29 Cytomagalovirus IG IV CMVIG 30 Hepatitis B immune globulin HBIG 32 Meningococcal polysaccharide MPSV4 33 Pneumoccocal polysaccharide PPSV23 34 Rabies immune globulin RIG 35 Tetanus toxoid, adsorbed TT 36 Varicella zoster immune globulin VZIG 37 Yellow fever (YF-VAX) YELLOW FEVER (YF-VAX) 38 Rubella and mumps virus MUMPS-RUB 39 Japanese encephalitis, SC JENCEPH SC 40 Rabies, intradermal RABIES ID 41 Typhoid, parenteral, non-AKD TYPHOID PAR 42 Hepatitis B, adol/high risk infant HEP B HIGH RISK 43 Hepatitis B, adult HEP B ADULT 44 Hepatitis B, dialysis HEP B DIALYSIS 45 Hepatitis B, unspecified HEP B UNK 46 Haemophilus influenza type B, PRP-D HIB PRP-D 47嗜血杆菌流感B，HBOC HIB HBOC 48嗜血杆菌B型B型，Prp-T Hib Prp-t